Business Context and Reporting Period
Company: Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2026
Context: The Company is an emerging growth company listed on The Nasdaq Stock Market LLC. This filing addresses a regulatory compliance issue regarding the delayed submission of its Quarterly Report on Form 10-Q for the period ended June 30, 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the procedural status of a delayed financial report rather than disclosing new financial data.
Material Changes and Events
- Delisting Notice: On August 28, 2026, the Company received a notification from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to the failure to timely file the Form 10-Q for the quarter ended June 30, 2026.
- Trading Status: The notice has no immediate effect on the listing or trading of the Company's common stock, though Nasdaq will broadcast an indicator noting the noncompliance.
- Compliance Timeline: The Company has 60 calendar days (until October 27, 2026) to submit a plan to regain compliance.
Outlook, Risks, and Management Commentary
Management Action: The Company states it is working diligently to complete the Form 10-Q and intends to file it as soon as practicable.
Compliance Path: If Nasdaq accepts the Company's plan, an extension of up to 180 calendar days (until February 22, 2027) may be granted to regain compliance. There is no assurance that the plan will be accepted or that compliance will be achieved within any extension period.
Risks:
- Delisting Risk: Failure to timely regain compliance will result in the delisting of the Company's common stock from Nasdaq.
- Appeal Process: If the plan is rejected, the Company may appeal the decision to a Nasdaq hearings panel.
- Forward-Looking Uncertainty: Actual outcomes depend on the timing of the independent registered public accounting firm's review and the Company's ability to file the report.
Investor Verification Checklist
- Verify the status of the Form 10-Q for the period ended June 30, 2026, and the specific reasons for the delay.
- Monitor the Company's submission of a compliance plan to Nasdaq by the October 27, 2026 deadline.
- Confirm whether Nasdaq accepts the compliance plan and grants an extension period.
- Review the Company's subsequent filings for any updates on the delisting risk or trading status indicators.